Notably, 60%–90% of post‐transplant PFIC1 patients develop hepatic steatosis or steatohepatitis [7, 8], a condition recently linked to intestinal deficiency of ATP8B1 [9]. The gene discussed is ATP8B1; the disease is Hepatic steatosis.